CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 485 enrolled
Drug / intervention
Distal pancreatectomyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03030209
NCT03030209N/ACompleted
CompareCT.gov

Risk Factors for the Development of Diabetes Mellitus After Distal Pancreatectomy

Peking Union Medical College Hospital·observational·Posted Jan 24, 2017·Updated Sep 2, 2020

In Brief

An observational study evaluating Distal pancreatectomy for Diabetes Mellitus. Completed, enrolled 485 participants across 1 site.

Detailed Summary

Glucose homeostasis changes after distal pancreatectomy are not well understood. This study aim to identify the incidence of and risk factors for, a change in glucose homeostasis in patients who underwent distal pancreatic resection.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 24, 2017
Enrollment StartJan 1, 2004
Primary CompletionFeb 13, 2016
TodayJul 2, 2026
Enrollment to primary: 12.1 yearsPosted 9.4 years ago

Interventions

Distal pancreatectomyprocedure

Distal pancreatectomy with or without splenectomy using minimal invasive or open approach